Nonpatentable drugs and the cost of our ignorance

被引：11

作者：

Calon, F

机构：

[1] Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada

[2] Univ Laval, Fac Pharm, Quebec City, PQ, Canada

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2006年 / 174卷 / 04期

关键词：

D O I：

10.1503/cmaj.050663

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：483 / 484

页数：2

共 33 条

[1]

ANGELL M, 2005, TRUTH DRUG CO

[2]

[Anonymous], FACTS STAT OST ITS I

[3]

Bentham P, 2004, LANCET, V363, P2105

[4]

Brown JP, 2003, CAN MED ASSOC J, V168, P676

[5]

Brown JP, 2003, CAN MED ASSOC J, V168, P400

[6]

Brown JP, 2003, CAN MED ASSOC J, V168, P544

[7]

Brown JP, 2002, CAN MED ASSOC J, V167, pS1

[8] Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model [J].

Calon, F ;

Lim, GP ;

Yang, FS ;

Morihara, T ;

Teter, B ;

Ubeda, O ;

Rostaing, P ;

Triller, A ;

Salem, N ;

Ashe, KH ;

Frautschy, SA ;

Cole, GM .

NEURON, 2004, 43 (05) :633-645

[9]

*CAN I HLTH RES, 2004, CIHR ANN REP 2003 20

[10]

*CENTERWATCH CLIN, THOM CENTERWATCH AN

← 1 2 3 4 →